Search by Drug Name or NDC
NDC 00078-0698-19 RYDAPT 25 mg/1 Details
RYDAPT 25 mg/1
RYDAPT is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is MIDOSTAURIN.
MedlinePlus Drug Summary
Midostaurin is used with other chemotherapy drugs to treat certain types of acute myeloid leukemia (AML; a type of cancer of the white blood cells). Midostaurin is also used to certain types of mastocytosis (a blood disorder in which there are too many mast cells [a certain kind of white blood cell]). Midostaurin is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of mast and cancer cells.
Related Packages: 00078-0698-19Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Midostaurin
Product Information
NDC | 00078-0698 |
---|---|
Product ID | 0078-0698_d33f12ce-c74d-487e-81db-86fd5c265c94 |
Associated GPIs | 21533030000130 |
GCN Sequence Number | 077344 |
GCN Sequence Number Description | midostaurin CAPSULE 25 MG ORAL |
HIC3 | V1Q |
HIC3 Description | ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS |
GCN | 43327 |
HICL Sequence Number | 044227 |
HICL Sequence Number Description | MIDOSTAURIN |
Brand/Generic | Brand |
Proprietary Name | RYDAPT |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | RYDAPT |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE, LIQUID FILLED |
Route | ORAL |
Active Ingredient Strength | 25 |
Active Ingredient Units | mg/1 |
Substance Name | MIDOSTAURIN |
Labeler Name | Novartis Pharmaceuticals Corporation |
Pharmaceutical Class | Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA207997 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0698-19 (00078069819)
NDC Package Code | 0078-0698-19 |
---|---|
Billing NDC | 00078069819 |
Package | 4 CARTON in 1 CARTON (0078-0698-19) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02) |
Marketing Start Date | 2017-04-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |